In this study, we tested nine protein markers, among which CEA and CA19-9 were recommended in the Chinese expert consensus on experimental diagnostic technology for screening of early CRC and precancerous lesions [31]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.